Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Carter

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Lipid Mediators|March 1, 1993
A-78773: a selective, potent 5-lipoxygenase inhibitorR L Bell, D W Brooks, P R Young, et al.
Shock (Augusta, Ga.)|August 1, 1996
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious ratsD H Albert, G Luo, T J Magoc, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
Journal of Medicinal Chemistry|May 29, 1992
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonistsD E Guinn, J B Summers, H R Heyman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanismsK I Hulkower, E R Otis, J Li, et al.
Journal of Medicinal Chemistry|March 1, 1990
Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationshipsJ B Summers, K H Kim, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1997
ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway ratsD H Albert, P Tapang, D W Morgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
ABT-761 attenuates bronchoconstriction and pulmonary inflammation in rodentsR L Bell, R R Harris, P E Malo, et al.
Agents and Actions|March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitorR L Bell, J Bouska, P R Young, et al.
Annals of the New York Academy of Sciences|November 15, 1994
Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773G W Carter, R L Bell, K Marsh, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Lipid Mediators|March 1, 1993
A-78773: a selective, potent 5-lipoxygenase inhibitorR L Bell, D W Brooks, P R Young, et al.
Shock (Augusta, Ga.)|August 1, 1996
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious ratsD H Albert, G Luo, T J Magoc, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
Journal of Medicinal Chemistry|May 29, 1992
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonistsD E Guinn, J B Summers, H R Heyman, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanismsK I Hulkower, E R Otis, J Li, et al.
Journal of Medicinal Chemistry|March 1, 1990
Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationshipsJ B Summers, K H Kim, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1997
ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway ratsD H Albert, P Tapang, D W Morgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
ABT-761 attenuates bronchoconstriction and pulmonary inflammation in rodentsR L Bell, R R Harris, P E Malo, et al.
Agents and Actions|March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitorR L Bell, J Bouska, P R Young, et al.
Annals of the New York Academy of Sciences|November 15, 1994
Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773G W Carter, R L Bell, K Marsh, et al.
Pageof 8